Why spending on new medicines is more sustainable than other healthcare costs
The Canadian Life and Health Insurance Association (CLHIA), which represents the private health insurance industry, says that the cost of new medicines threatens the sustainability of private drug plans – and they want government to do something about it.
Last fall, CLHIA’s president commented in the National Post that, “high drug costs are eating away at our health system” and that “the increasing number of very expensive drugs that treat relatively rare diseases threatens the financial sustainability of the entire system.” Since then, the industry has actively called for increased government intervention and regulation of the Canadian pharmaceutical industry.
Brett Skinner Reports
Dianne Doyle, President & CEO, and Geoff Plant, Chair, PHC Board of Directors